Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Denali, Lonza collaborate on biologics for neurodegenerative diseases

Executive Summary

Denali Therapeutics Inc. is collaborating with Lonza Group Ltd. to advance Denali’s biologic pipeline of neurodegenerative disease compounds through all stages of development and manufacturing.
Deal Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Large Molecule
    • Synthesis Technologies, Production Processes
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register